| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,097,507 | 3,171,617 | 2,683,049 | | Cost of Revenue | 401,989 | 335,192 | 274,383 | | | Gross Profit | 3,695,518 | 2,836,425 | 2,408,666 | | | Operating Expenses | | Research Development | 1,072,058 | 925,164 | 718,390 | | Selling General and Administrative | 925,305 | 776,103 | 685,067 | | Non Recurring | 15,758 | 83,812 | 298,191 | | Others | 468,786 | 271,574 | 266,998 | | | | Total Operating Expenses | 2,481,907 | 2,056,653 | 1,968,646 | | | | Operating Income or Loss | 1,213,611 | 779,772 | 440,020 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (64,668) | 130,823 | 59,784 | | Earnings Before Interest And Taxes | 1,148,943 | 910,595 | 493,034 | | Interest Expense |
-
|
-
| 871 | | Income Before Tax | 1,148,943 | 910,595 | 492,163 | | Income Tax Expense | 365,776 | 272,423 | 278,431 | | Minority Interest |
-
|
-
| (6,770) | | | | Net Income From Continuing Ops | 783,167 | 638,172 | 213,732 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 3,779 | | Other Items |
-
|
-
|
-
| | | | Net Income | 783,167 | 638,172 | 217,511 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $783,167 | $638,172 | $217,511 |
|
0.16% Nasdaq 0.00%
Income Statement
